Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases

Biochemical Pharmacology

Volumn 80, Issue 11, 2010, Pages 1613-1631

  Aggarwal, Bharat B ^a   Sundaram, Chitra ^a   Prasad, Seema ^a   Kannappan, Ramaswamy ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Anticancer; Atherosclerosis; Bone resorption; Cholesterol; Diabetes; Neuroprotective; Tocotrienols

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CORN OIL; DEATH RECEPTOR 5; DELTA TOCOTRIENOL; DNA POLYMERASE; ESTROGEN RECEPTOR; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEVINOLIN; PALMVITEE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLACEBO; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TOCOPHEROL; TOCOTRIENYL ACETATE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BONE METABOLISM; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; DYSAUTONOMIA; ENZYME INHIBITION; FIBROSARCOMA; GENE MUTATION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VITRO STUDY; LIPID METABOLISM; LIVER TUMOR; LUNG TUMOR; NEOPLASM; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; NOTE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; SMOKING; STOMACH FUNCTION; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; VITAMIN SUPPLEMENTATION; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; METABOLISM; NEOPLASMS; TRENDS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; TOCOTRIENOLS; VITAMIN E;

EID: 77957909450     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.07.043     Document Type: Note

References (250)

1. Sen C.K., Khanna S., Rink C., Roy S. Tocotrienols: the emerging face of natural vitamin E. Vitam Horm 2007, 76:203-261.
2. Qureshi A.A., Sami S.A., Salser W.A., Khan F.A. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 2001, 12:318-329.
3. Qureshi A.A., Sami S.A., Salser W.A., Khan F.A. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002, 161:199-207.
4. Bunyan J., Mc H.D., Green J., Marcinkiewicz S. Biological potencies of epsilon- and zeta-1-tocopherol and 5-methyltocol. Br J Nutr 1961, 15:253-257.
5. Dunphy P.J., Whittle K.J., Pennock J.F., Morton R.A. Identification and estimation of tocotrienols in Hevea latex. Nature 1965, 201:521-522.
6. Whittle K.J., Dunphy P.J., Pennock J.F. The isolation and properties of delta-tocotrienol from Hevea latex. Biochem J 1966, 100:138-145.
7. Qureshi A.A., Burger W.C., Peterson D.M., Elson C.E. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 1986, 261:10544-10550.
8. Kato A., Yamaoka M., Tanaka A., Komiyama Ka, Umezawa I. Physiological effect of tocotrienol. J Jpn Oil Chem Soc (Yukugaku) 1985, 34:375-376.
9. Sundram K., Khor H.T., Ong A.S., Pathmanathan R. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Res 1989, 49:1447-1451.
10. Tan B. Tocotrienols: The New Vitamin E. Spacedocnet, March 10, 2010. http://www.spacedoc.net/.
11. Kobayashi H., Kanno C., Yamauchi K., Tsugo T. Identification of alpha-, beta-, gamma-, and delta-tocopherols and their contents in human milk. Biochim Biophys Acta 1975, 380:282-290.
12. van Haaften R.I., Haenen G.R., Evelo C.T., Bast A. Tocotrienols inhibit human glutathione S-transferase P1-1. IUBMB Life 2002, 54:81-84.
13. Comitato R., Nesaretnam K., Leoni G., Ambra R., Canali R., Bolli A., et al. A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction. Am J Physiol Endocrinol Metab 2009, 297:E427-E437.
14. Upadhyay J., Misra K. Towards the interaction mechanism of tocopherols and tocotrienols (vitamin E) with selected metabolizing enzymes. Bioinformation 2009, 3:326-331.
15. Zhou C., Tabb M.M., Sadatrafiei A., Grun F., Blumberg B. Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes. Drug Metab Dispos 2004, 32:1075-1082.
16. Khanna S., Roy S., Park H.A., Sen C.K. Regulation of c-Src activity in glutamate-induced neurodegeneration. J Biol Chem 2007, 282:23482-23490.
17. Khanna S., Roy S., Ryu H., Bahadduri P., Swaan P.W., Ratan R.R., et al. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 2003, 278:43508-43515.
18. Lee S.P., Mar G.Y., Ng L.T. Effects of tocotrienol-rich fraction on exercise endurance capacity and oxidative stress in forced swimming rats. Eur J Appl Physiol 2009, 107:587-595.
19. Newaz M.A., Nawal N.N. Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin Exp Hypertens 1999, 21:1297-1313.
20. Hsieh T.C., Wu J.M. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol 2008, 33:851-859.
21. Adam A., Marzuki A., Ngah W.Z., Top G.M. Nitrofurantoin-induced hepatic and pulmonary biochemical changes in mice fed different vitamin E doses. Pharmacol Toxicol 1996, 79:334-339.
22. Renuka Devi R., Arumughan C. Antiradical efficacy of phytochemical extracts from defatted rice bran. Food Chem Toxicol 2007, 45:2014-2021.
23. Weng-Yew W., Selvaduray K.R., Ming C.H., Nesaretnam K. Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr Cancer 2009, 61:367-373.
24. Rashid S.A., Halim A.S., Muhammad N.A. The effect of vitamin E on basic fibroblast growth factor level in human fibroblast cell culture. Med J Malay 2008, 63(Suppl. A):69-70.
25. Shun M.C., Yu W., Gapor A., Parsons R., Atkinson J., Sanders B.G., et al. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 2004, 48:95-105.
26. Pierpaoli E., Viola V., Pilolli F., Piroddi M., Galli F., Provinciali M. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression. Life Sci 2010, 86:668-675.
27. Wu S.J., Ng L.T. Tocotrienols inhibited growth and induced apoptosis in human HeLa cells through the cell cycle signaling pathway. Integr Cancer Ther 2010, 9:66-72.
28. Agarwal M.K., Agarwal M.L., Athar M., Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 2004, 3:205-211.
29. Samant G.V., Wali V.B., Sylvester P.W. Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression. Cell Prolif 2010, 43:77-83.
30. Elangovan S., Hsieh T.C., Wu J.M. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res 2008, 28:2641-2647.
31. Wali V.B., Bachawal S.V., Sylvester P.W. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1. Exp Biol Med (Maywood) 2009, 234:639-650.
32. Sun W., Wang Q., Chen B., Liu J., Liu H., Xu W. Gamma-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br J Nutr 2008, 99:1247-1254.
33. Park S.K., Sanders B.G., Kline K. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat 2010.
34. Ahn K.S., Sethi G., Krishnan K., Aggarwal B.B. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem 2007, 282:809-820.
35. Gysin R., Azzi A., Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 2002, 16:1952-1954.
36. Samant G.V., Sylvester P.W. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Prolif 2006, 39:563-574.
37. Eitsuka T., Nakagawa K., Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem Biophys Res Commun 2006, 348:170-175.
38. Shah S., Sylvester P.W. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med (Maywood) 2004, 229:745-755.
39. Rickmann M., Vaquero E.C., Malagelada J.R., Molero X. Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology 2007, 132:2518-2532.
40. Sakai M., Okabe M., Tachibana H., Yamada K. Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 2006, 17:672-676.
41. Xu W.L., Liu J.R., Liu H.K., Qi G.Y., Sun X.R., Sun W.G., et al. Inhibition of proliferation and induction of apoptosis by gamma-tocotrienol in human colon carcinoma HT-29 cells. Nutrition 2009, 25:555-566.
42. Shah S.J., Sylvester P.W. Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem Cell Biol 2005, 83:86-95.
43. Takahashi K., Loo G. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem Pharmacol 2004, 67:315-324.
44. Sun W., Xu W., Liu H., Liu J., Wang Q., Zhou J., et al. gamma-Tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem 2009, 20:276-284.
45. Sylvester P.W., Shah S. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J Clin Nutr 2005, 14:366-373.
46. Srivastava J.K., Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 2006, 346:447-453.
47. Shibata A., Nakagawa K., Sookwong P., Tsuduki T., Tomita S., Shirakawa H., et al. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha. J Nutr 2008, 138:2136-2142.
48. Miyazawa T., Shibata A., Nakagawa K., Tsuzuki T. Anti-angiogenic function of tocotrienol. Asia Pac J Clin Nutr 2008, 17(Suppl 1):253-256.
49. Nakagawa K., Eitsuka T., Inokuchi H., Miyazawa T. DNA chip analysis of comprehensive food function: inhibition of angiogenesis and telomerase activity with unsaturated vitamin E, tocotrienol. Biofactors 2004, 21:5-10.
50. Shibata A., Nakagawa K., Sookwong P., Tsuduki T., Oikawa S., Miyazawa T. delta-Tocotrienol suppresses VEGF induced angiogenesis whereas alpha-tocopherol does not. J Agric Food Chem 2009, 57:8696-8704.
51. Liu H.K., Wang Q., Li Y., Sun W.G., Liu J.R., Yang Y.M., et al. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem 2010, 21:206-213.
52. Shirode A.B., Sylvester P.W. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. Biomed Pharmacother 2010, 64:327-332.
53. Kuhad A., Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci 2009, 84:296-301.
54. Norazlina M., Lee P.L., Lukman H.I., Nazrun A.S., Ima-Nirwana S. Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats. Singapore Med J 2007, 48:195-199.
55. Ahmad N.S., Khalid B.A., Luke D.A., Ima Nirwana S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin Exp Pharmacol Physiol 2005, 32:761-770.
56. Wu S.J., Liu P.L., Ng L.T. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res 2008, 52:921-929.
57. Jiang Q., Yin X., Lill M.A., Danielson M.L., Freiser H., Huang J. Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. Proc Natl Acad Sci USA 2008, 105:20464-20469.
58. Kashiwagi K., Virgona N., Harada K., Kido W., Yano Y., Ando A., et al. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells. Life Sci 2009, 84:650-656.
59. Bachawal S.V., Wali V.B., Sylvester P.W. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells. Anticancer Res 2010, 30:429-437.
60. Ozer N.K., Boscoboinik D., Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int 1995, 35:117-124.
61. Sen C.K., Khanna S., Roy S., Packer L. Molecular basis of vitamin E action, tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 2000, 275:13049-13055.
62. Sylvester P.W., Shah S.J., Samant G.V. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells. J Plant Physiol 2005, 162:803-810.
63. Qureshi A.A., Pearce B.C., Nor R.M., Gapor A., Peterson D.M., Elson C.E. Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr 1996, 126:389-394.
64. Elson C.E., Qureshi A.A. Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Prostaglandins Leukot Essent Fatty Acids 1995, 52:205-207.
65. Iqbal J., Minhajuddin M., Beg Z.H. Suppression of 7,12-dimethylbenz[alpha]anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J Cancer Prev 2003, 12:447-453.
66. Parker R.A., Pearce B.C., Clark R.W., Gordon D.A., Wright J.J. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1993, 268:11230-11238.
67. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., Wright J.J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 1992, 35:3595-3606.
68. Ali H., Shirode A.B., Sylvester P.W., Nazzal S. Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles. Int J Pharm 2010, 389:223-231.
69. Bachawal S.V., Wali V.B., Sylvester P.W. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells. BMC Cancer 2010, 10:84.
70. McIntyre B.S., Briski K.P., Gapor A., Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 2000, 224:292-301.
71. Wali V.B., Bachawal S.V., Sylvester P.W. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment. Lipids 2009, 44:925-934.
72. Wali V.B., Bachawal S.V., Sylvester P.W. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells. Apoptosis 2009, 14:1366-1377.
73. Guthrie N., Gapor A., Chambers A.F., Carroll K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 1997, 127:S544-S548.
74. Nesaretnam K., Guthrie N., Chambers A.F., Carroll K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 1995, 30:1139-1143.
75. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33:461-469.
76. Shah S., Gapor A., Sylvester P.W. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 2003, 45:236-246.
77. Sylvester P.W., Nachnani A., Shah S., Briski K.P. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr 2002, 11(Suppl. 7):S452-S459.
78. Sylvester P.W., Shah S.J. Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front Biosci 2005, 10:699-709.
79. Yang Z., Xiao H., Jin H., Koo P.T., Tsang D.J., Yang C.S. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. Int J Cancer 2010, 126:852-863.
80. Har C.H., Keong C.K. Effects of tocotrienols on cell viability and apoptosis in normal murine liver cells (BNL CL.2) and liver cancer cells (BNL 1ME A.7R.1), in vitro. Asia Pac J Clin Nutr 2005, 14:374-380.
81. Sakai M., Okabe M., Yamasaki M., Tachibana H., Yamada K. Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res 2004, 24:1683-1688.
82. Wada S., Satomi Y., Murakoshi M., Noguchi N., Yoshikawa T., Nishino H. Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett 2005, 229:181-191.
83. Kashiwagi K., Harada K., Yano Y., Kumadaki I., Hagiwara K., Takebayashi J., et al. A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells. Biochem Biophys Res Commun 2008, 365:875-881.
84. Nakashima K., Virgona N., Miyazawa M., Watanabe T., Yano T. The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells. Phytother Res 2010.
85. Yano Y., Satoh H., Fukumoto K., Kumadaki I., Ichikawa T., Yamada K., et al. Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox-silent derivative of alpha-tocotrienol. Int J Cancer 2005, 115:839-846.
86. Chang P.N., Yap W.N., Lee D.T., Ling M.T., Wong Y.C., Yap Y.L. Evidence of gamma-tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutr Cancer 2009, 61:357-366.
87. McAnally J.A., Gupta J., Sodhani S., Bravo L., Mo H. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood) 2007, 232:523-531.
88. Hussein D., Mo H. Delta-tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 2009, 38:e124-e136.
89. Constantinou C., Hyatt J.A., Vraka P.S., Papas A., Papas K.A., Neophytou C., et al. Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives. Nutr Cancer 2009, 61:864-874.
90. Conte C., Floridi A., Aisa C., Piroddi M., Galli F. Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann N Y Acad Sci 2004, 1031:391-394.
91. Yap W.N., Chang P.N., Han H.Y., Lee D.T., Ling M.T., Wong Y.C., et al. Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br J Cancer 2008, 99:1832-1841.
92. Comitato R., Leoni G., Canali R., Ambra R., Nesaretnam K., Virgili F. Tocotrienols activity in MCF-7 breast cancer cells: involvement of ERbeta signal transduction. Mol Nutr Food Res 2010, 64:327-332.
93. Kamat J.P., Sarma H.D., Devasagayam T.P., Nesaretnam K., Basiron Y. Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol Cell Biochem 1997, 170:131-137.
94. Yu W., Simmons-Menchaca M., Gapor A., Sanders B.G., Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 1999, 33:26-32.
95. Chao J.T., Gapor A., Theriault A. Inhibitory effect of delta-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion. J Nutr Sci Vitaminol (Tokyo) 2002, 48:332-337.
96. Pearce B.C., Parker R.A., Deason M.E., Dischino D.D., Gillespie E., Qureshi A.A., et al. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J Med Chem 1994, 37:526-541.
97. Theriault A., Chao J.T., Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 2002, 160:21-30.
98. Khanna S., Roy S., Parinandi N.L., Maurer M., Sen C.K. Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol. J Neurochem 2006, 98:1474-1486.
99. Liu X., Yamada N., Osawa T. Assessing the neuroprotective effect of antioxidative food factors by application of lipid-derived dopamine modification adducts. Methods Mol Biol 2009, 580:143-152.
100. Komiyama K., Iizuka K., Yamaoka M., Watanabe H., Tsuchiya N., Umezawa I. Studies on the biological activity of tocotrienols. Chem Pharm Bull (Tokyo) 1989, 37:1369-1371.
101. He L., Mo H., Hadisusilo S., Qureshi A.A., Elson C.E. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 1997, 127:668-674.
102. Hiura Y., Tachibana H., Arakawa R., Aoyama N., Okabe M., Sakai M., et al. Specific accumulation of gamma- and delta-tocotrienols in tumor and their antitumor effect in vivo. J Nutr Biochem 2009, 20:607-613.
103. Nakagawa K., Shibata A., Yamashita S., Tsuzuki T., Kariya J., Oikawa S., et al. In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol. J Nutr 2007, 137:1938-1943.
104. Kumar K.S., Raghavan M., Hieber K., Ege C., Mog S., Parra N., et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci 2006, 78:2099-2104.
105. Gould M.N., Haag J.D., Kennan W.S., Tanner M.A., Elson C.E. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am J Clin Nutr 1991, 53:1068S-1070S.
106. Goh S.H., Hew N.F., Norhanom A.W., Yadav M. Inhibition of tumour promotion by various palm-oil tocotrienols. Int J Cancer 1994, 57:529-531.
107. Iqbal J., Minhajuddin M., Beg Z.H. Suppression of diethylnitrosamine and 2-acetylaminofluorene-induced hepatocarcinogenesis in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J Cancer Prev 2004, 13:515-520.
108. Ngah W.Z., Jarien Z., San M.M., Marzuki A., Top G.M., Shamaan N.A., et al. Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats. Am J Clin Nutr 1991, 53:1076S-1081S.
109. Rahmat A., Ngah W.Z., Shamaan N.A., Gapor A., Abdul Kadir K. Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition 1993, 9:229-232.
110. Shamaan N.A., Wan Ngah W.Z., Ibrahim R., Jarien Z., Top A.G., Abdul Kadir K. Effect of tocotrienol on the activities of cytosolic glutathione-dependent enzymes in rats treated with 2-acetylaminofluorene. Biochem Pharmacol 1993, 45:1517-1519.
111. Koba K., Abe K., Ikeda I., Sugano M. Effects of alpha-tocopherol and tocotrienols on blood pressure and linoleic acid metabolism in the spontaneously hypertensive rat (SHR). Biosci Biotechnol Biochem 1992, 56:1420-1423.
112. Chen C.W., Cheng H.H. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr 2006, 136:1472-1476.
113. Chou T.W., Ma C.Y., Cheng H.H., Chen Y.Y., Lai M.H. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 2009, 45:29-36.
114. Nafeeza M.I., Norzana A.G., Jalaluddin H.L., Gapor M.T. The effects of a tocotrienol-rich fraction on experimentally induced atherosclerosis in the aorta of rabbits. Malays J Pathol 2001, 23:17-25.
115. Das S., Lekli I., Das M., Szabo G., Varadi J., Juhasz B., et al. Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol 2008, 294:H970-H978.
116. Qureshi A.A., Peterson D.M., Hasler-Rapacz J.O., Rapacz J. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 2001, 131:223-230.
117. Esterhuyse A.J., Toit E.D., Rooyen J.V. Dietary red palm oil supplementation protects against the consequences of global ischemia in the isolated perfused rat heart. Asia Pac J Clin Nutr 2005, 14:340-347.
118. Das M., Das S., Wang P., Powell S.R., Das D.K. Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem 2008, 22:287-294.
119. Lekli I., Ray D., Mukherjee S., Gurusamy N., Ahsan M.K., Juhasz B., et al. Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. J Cell Mol Med 2009.
120. Wan Nazaimoon W.M., Khalid B.A. Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays J Pathol 2002, 24:77-82.
121. Budin S.B., Othman F., Louis S.R., Bakar M.A., Das S., Mohamed J. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo) 2009, 64:235-244.
122. Kuhad A., Bishnoi M., Tiwari V., Chopra K. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 2009, 92:251-259.
123. Kuhad A., Chopra K. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 2009, 57:456-462.
124. Kanaya Y., Doi T., Sasaki H., Fujita A., Matsuno S., Okamoto K., et al. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Res Clin Pract 2004, 66(Suppl. 1):S157-S160.
125. Yoshida Y., Hayakawa M., Habuchi Y., Itoh N., Niki E. Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane. Lipids 2007, 42:463-472.
126. Fang F., Kang Z., Wong C. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol Nutr Food Res 2010, 54:345-352.
127. Tiwari V., Kuhad A., Bishnoi M., Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav 2009, 93:183-189.
128. Tiwari V., Kuhad A., Chopra K. Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain 2009, 145:129-135.
129. Tiwari V., Kuhad A., Chopra K. Suppression of neuro-inflammatory signaling cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction in rats. Behav Brain Res 2009, 203:296-303.
130. Khanna S., Parinandi N.L., Kotha S.R., Roy S., Rink C., Bibus D., et al. Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. J Neurochem 2010, 112:1249-1260.
131. Khanna S., Roy S., Slivka A., Craft T.K., Chaki S., Rink C., et al. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005, 36:2258-2264.
132. Roy S., Lado B.H., Khanna S., Sen C.K. Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett 2002, 530:17-23.
133. Mishima K., Tanaka T., Pu F., Egashira N., Iwasaki K., Hidaka R., et al. Vitamin E isoforms alpha-tocotrienol and gamma-tocopherol prevent cerebral infarction in mice. Neurosci Lett 2003, 337:56-60.
134. Hermizi H., Faizah O., Ima-Nirwana S., Ahmad Nazrun S., Norazlina M. Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcif Tissue Int 2009, 84:65-74.
135. Mehat M.Z., Shuid A.N., Mohamed N., Muhammad N., Soelaiman I.N. Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats. J Bone Miner Metab 2010.
136. Shuid A.N., Mehat Z., Mohamed N., Muhammad N., Soelaiman I.N. Vitamin E exhibits bone anabolic actions in normal male rats. J Bone Miner Metab 2010, 28:149-156.
137. Maniam S., Mohamed N., Shuid A.N., Soelaiman I.N. Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol. Basic Clin Pharmacol Toxicol 2008, 103:55-60.
138. Norazlina M., Ima-Nirwana S., Abul Gapor M.T., Abdul Kadir Khalid B. Tocotrienols are needed for normal bone calcification in growing female rats. Asia Pac J Clin Nutr 2002, 11:194-199.
139. Ima-Nirwana S., Suhaniza S. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J Med Food 2004, 7:45-51.
140. Gu J.Y., Wakizono Y., Sunada Y., Hung P., Nonaka M., Sugano M., et al. Dietary effect of tocopherols and tocotrienols on the immune function of spleen and mesenteric lymph node lymphocytes in Brown Norway rats. Biosci Biotechnol Biochem 1999, 63:1697-1702.
141. Azlina M.F., Nafeeza M.I., Khalid B.A. A comparison between tocopherol and tocotrienol effects on gastric parameters in rats exposed to stress. Asia Pac J Clin Nutr 2005, 14:358-365.
142. Nafeeza M.I., Fauzee A.M., Kamsiah J., Gapor M.T. Comparative effects of a tocotrienol-rich fraction and tocopherol in aspirin-induced gastric lesions in rats. Asia Pac J Clin Nutr 2002, 11:309-313.
143. Freiser H., Jiang Q. Gamma-tocotrienol and gamma-tocopherol are primarily metabolized to conjugated 2-(beta-carboxyethyl)-6-hydroxy-2,7,8-trimethylchroman and sulfated long-chain carboxychromanols in rats. J Nutr 2009, 139:884-889.
144. Hattori A., Fukushima T., Yoshimura H., Abe K., Imai K. Production of LLU-alpha following an oral administration of gamma-tocotrienol or gamma-tocopherol to rats. Biol Pharm Bull 2000, 23:1395-1397.
145. Husain K., Francois R.A., Hutchinson S.Z., Neuger A.M., Lush R., Coppola D., et al. Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration. Pharmacology 2009, 83:157-163.
146. Ikeda I., Imasato Y., Sasaki E., Sugano M. Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats. Int J Vitam Nutr Res 1996, 66:217-221.
147. Ikeda S., Niwa T., Yamashita K. Selective uptake of dietary tocotrienols into rat skin. J Nutr Sci Vitaminol (Tokyo) 2000, 46:141-143.
148. Ikeda S., Toyoshima K., Yamashita K. Dietary sesame seeds elevate alpha- and gamma-tocotrienol concentrations in skin and adipose tissue of rats fed the tocotrienol-rich fraction extracted from palm oil. J Nutr 2001, 131:2892-2897.
149. Kawakami Y., Tsuzuki T., Nakagawa K., Miyazawa T. Distribution of tocotrienols in rats fed a rice bran tocotrienol concentrate. Biosci Biotechnol Biochem 2007, 71:464-471.
150. Khosla P., Patel V., Whinter J.M., Khanna S., Rakhkovskaya M., Roy S., et al. Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 2006, 8:1059-1068.
151. Saito Y., Yoshida Y., Nishio K., Hayakawa M., Niki E. Characterization of cellular uptake and distribution of vitamin E. Ann N Y Acad Sci 2004, 1031:368-375.
152. Tanito M., Itoh N., Yoshida Y., Hayakawa M., Ohira A., Niki E. Distribution of tocopherols and tocotrienols to rat ocular tissues after topical ophthalmic administration. Lipids 2004, 39:469-474.
153. Tasaki M., Umemura T., Inoue T., Okamura T., Kuroiwa Y., Ishii Y., et al. Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year. Toxicology 2008, 250:143-150.
154. Tsuzuki W., Yunoki R., Yoshimura H. Intestinal epithelial cells absorb gamma-tocotrienol faster than alpha-tocopherol. Lipids 2007, 42:163-170.
155. Yap S.P., Yuen K.H., Lim A.B. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. J Pharm Pharmacol 2003, 55:53-58.
156. Qureshi A.A., Qureshi N., Hasler-Rapacz J.O., Weber F.E., Chaudhary V., Crenshaw T.D., et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 1991, 53:1042S-1046S.
157. Nakamura H., Furukawa F., Nishikawa A., Miyauchi M., Son H.Y., Imazawa T., et al. Oral toxicity of a tocotrienol preparation in rats. Food Chem Toxicol 2001, 39:799-805.
158. O'Byrne D., Grundy S., Packer L., Devaraj S., Baldenius K., Hoppe P.P., et al. Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 2000, 29:834-845.
159. Hayes K.C., Pronczuk A., Liang J.S. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters. Proc Soc Exp Biol Med 1993, 202:353-359.
160. Yap S.P., Yuen K.H., Wong J.W. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 2001, 53:67-71.
161. Lodge J.K., Ridlington J., Leonard S., Vaule H., Traber M.G. Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 2001, 36:43-48.
162. Yap S.P., Yuen K.H. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm 2004, 281:67-78.
163. Ajuluchukwu J.N., Okubadejo N.U., Mabayoje M., Ojini F.I., Okwudiafor R.N., Mbakwem A.C., et al. Comparative study of the effect of tocotrienols and -tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report. Niger Postgrad Med J 2007, 14:30-33.
164. Baliarsingh S., Beg Z.H., Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005, 182:367-374.
165. Qureshi A.A., Bradlow B.A., Brace L., Manganello J., Peterson D.M., Pearce B.C., et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995, 30:1171-1177.
166. Qureshi A.A., Bradlow B.A., Salser W.A., Brace L.D. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr Biochem 1997, 8:290-298.
167. Qureshi A.A., Qureshi N., Wright J.J., Shen Z., Kramer G., Gapor A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 1991, 53:1021S-1026S.
168. Rasool A.H., Rahman A.R., Yuen K.H., Wong A.R. Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E. Arch Pharm Res 2008, 31:1212-1217.
169. Roza J.M., Xian-Liu Z., Guthrie N. Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects. Altern Ther Health Med 2007, 13:44-48.
170. Tan D.T., Khor H.T., Low W.H., Ali A., Gapor A. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am J Clin Nutr 1991, 53:1027S-1030S.
171. Tomeo A.C., Geller M., Watkins T.R., Gapor A., Bierenbaum M.L. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 1995, 30:1179-1183.
172. Mensink R.P., van Houwelingen A.C., Kromhout D., Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 1999, 69:213-219.
173. Mustad V.A., Smith C.A., Ruey P.P., Edens N.K., DeMichele S.J. Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 2002, 76:1237-1243.
174. Rasool A.H., Yuen K.H., Yusoff K., Wong A.R., Rahman A.R. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol (Tokyo) 2006, 52:473-478.
175. Stampfer M.J., Willet W., Castelli W.P., Taylor J.O., Fine J., Hennekens C.H. Effect of vitamin E on lipids. Am J Clin Pathol 1983, 79:714-716.
176. Wahlqvist M.L., Krivokuca-Bogetic Z., Lo C.S., Hage B., Smith R., Lukito W. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolemic individuals without change in coronary risk factors. Nutr Res 1992, 12(Suppl.).
177. Anderson S.L., Rubin B.Y. Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia. Biochem Biophys Res Commun 2005, 336:150-156.
178. Rubin B.Y., Anderson S.L., Kapas L. Can the therapeutic efficacy of tocotrienols in neurodegenerative familial dysautonomia patients be measured clinically?. Antioxid Redox Signal 2008, 10:837-841.
179. Chin S.F., Hamid N.A., Latiff A.A., Zakaria Z., Mazlan M., Yusof Y.A., et al. Reduction of DNA damage in older healthy adults by Tri E tocotrienol supplementation. Nutrition 2008, 24:1-10.
180. Weber S.U., Thiele J.J., Han N., Luu C., Valacchi G., Weber S., et al. Topical alpha-tocotrienol supplementation inhibits lipid peroxidation but fails to mitigate increased transepidermal water loss after benzoyl peroxide treatment of human skin. Free Radic Biol Med 2003, 34:170-176.
181. Serbinova E., Kagan V., Han D., Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 1991, 10:263-275.
182. Suzuki Y.J., Tsuchiya M., Wassall S.R., Choo Y.M., Govil G., Kagan V.E., et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993, 32:10692-10699.
183. Yoshida Y., Niki E., Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 2003, 123:63-75.
184. Birringer M., Pfluger P., Kluth D., Landes N., Brigelius-Flohe R. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr 2002, 132:3113-3118.
185. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
186. Sigounas G., Anagnostou A., Steiner M. dl-Alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 1997, 28:30-35.
187. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., et al. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997, 409:105-108.
188. Inokuchi H., Hirokane H., Tsuzuki T., Nakagawa K., Igarashi M., Miyazawa T. Anti-angiogenic activity of tocotrienol. Biosci Biotechnol Biochem 2003, 67:1623-1627.
189. Miyazawa T., Tsuzuki T., Nakagawa K., Igarashi M. Antiangiogenic potency of vitamin E. Ann N Y Acad Sci 2004, 1031:401-404.
190. Suarna C., Hood R.L., Dean R.T., Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim Biophys Acta 1993, 1166:163-170.
191. Mazlan M., Sue Mian T., Mat Top G., Zurinah Wan Ngah W. Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J Neurol Sci 2006, 243:5-12.
192. Shichiri M., Takanezawa Y., Uchida K., Tamai H., Arai H. Protection of cerebellar granule cells by tocopherols and tocotrienols against methylmercury toxicity. Brain Res 2007, 1182:106-115.
193. Yam M.L., Abdul Hafid S.R., Cheng H.M., Nesaretnam K. Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids 2009, 44:787-797.
194. Serbinova E.A., Packer L. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol 1994, 234:354-366.
195. Miyazawa T., Inokuchi H., Hirokane H., Tsuzuki T., Nakagawa K., Igarashi M. Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Mosc) 2004, 69:67-69.
196. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Am Med Assoc 2009, 301:39-51.
197. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. J Am Med Assoc 2005, 293:1338-1347.
198. Schroeder M.T., Becker E.M., Skibsted L.H. Molecular mechanism of antioxidant synergism of tocotrienols and carotenoids in palm oil. J Agric Food Chem 2006, 54:3445-3453.
199. Sookwong P., Nakagawa K., Yamaguchi Y., Miyazawa T., Kato S., Kimura F. Tocotrienol distribution in foods: estimation of daily tocotrienol intake of Japanese population. J Agric Food Chem 2010, 58:3350-3355.
200. Hassanein M.M., Abedel-Razek A.G. Chromatographic quantitation of some bioactive minor components in oils of wheat germ and grape seeds produced as by-products. J Oleo Sci 2009, 58:227-233.
201. Amaral J.S., Casal S., Alves M.R., Seabra R.M., Oliveira B.P. Tocopherol and tocotrienol content of hazelnut cultivars grown in Portugal. J Agric Food Chem 2006, 54:1329-1336.
202. Cunha S.C., Amaral J.S., Fernandes J.O., Oliveira M.B. Quantification of tocopherols and tocotrienols in Portuguese olive oils using HPLC with three different detection systems. J Agric Food Chem 2006, 54:3351-3356.
203. Kallio H., Yang B., Peippo P., Tahvonen R., Pan R. Triacylglycerols, glycerophospholipids, tocopherols, and tocotrienols in berries and seeds of two subspecies (ssp. sinensis and mongolica) of Sea Buckthorn (Hippophae rhamnoides). J Agric Food Chem 2002, 50:3004-3009.
204. Milagros Delgado-Zamarreno M., Bustamante-Rangel M., Sierra-Manzano S., Verdugo-Jara M., Carabias-Martinez R. Simultaneous extraction of tocotrienols and tocopherols from cereals using pressurized liquid extraction prior to LC determination. J Sep Sci 2009, 32:1430-1436.
205. Panfili G., Fratianni A., Irano M. Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem 2003, 51:3940-3944.
206. Bozan B., Temelli F. Chemical composition and oxidative stability of flax, safflower and poppy seed and seed oils. Bioresour Technol 2008, 99:6354-6359.
207. Hafid S.R., Radhakrishnan A.K., Nesaretnam K. Tocotrienols are good adjuvants for developing cancer vaccines. BMC Cancer 2010, 10:5.
208. Naito Y., Shimozawa M., Kuroda M., Nakabe N., Manabe H., Katada K., et al. Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 2005, 180:19-25.
209. Noguchi N., Hanyu R., Nonaka A., Okimoto Y., Kodama T. Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 2003, 34:1614-1620.
210. Mizushina Y., Nakagawa K., Shibata A., Awata Y., Kuriyama I., Shimazaki N., et al. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochem Biophys Res Commun 2006, 339:949-955.
211. Makpol S., Shamaan N.A., Jarien Z., Top A.G., Khalid B.A., Wan Ngah W.Z. Different starting times of alpha-tocopherol and gamma-tocotrienol supplementation and tumor marker enzyme activities in the rat chemically induced with cancer. Gen Pharmacol 1997, 28:589-592.
212. Ong F.B., Wan Ngah W.Z., Shamaan N.A., Md Top A.G., Marzuki A., Khalid A.K. Glutathione S-transferase and gamma-glutamyl transpeptidase activities in cultured rat hepatocytes treated with tocotrienol and tocopherol. Comp Biochem Physiol C 1993, 106:237-240.
213. Ong F.B., Wan Ngah W.Z., Top A.G., Khalid B.A., Shamaan N.A. Vitamin E glutathione S-transferase and gamma-glutamyl transpeptidase activities in cultured hepatocytes of rats treated with carcinogens. Int J Biochem 1994, 26:397-402.
214. Shibata A., Nakagawa K., Sookwong P., Tsuzuki T., Oikawa S., Miyazawa T. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Biochem Pharmacol 2008, 76:330-339.
215. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 2003, 65:269-273.
216. Uto-Kondo H., Ohmori R., Kiyose C., Kishimoto Y., Saito H., Igarashi O., et al. Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. J Nutr 2009, 139:51-57.
217. Bi S., Liu J.R., Li Y., Wang Q., Liu H., Yan Y.G., et al. gamma-Tocotrienol modulates the paracrine secretion of VEGF induced by cobalt (II) chloride via ERK signaling pathway in gastric adenocarcinoma SGC-7901 cell line. Toxicology 2010, 274:27-33.
218. Li F., Tan W., Kang Z., Wong C.W. Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-activated receptors. Atherosclerosis 2010, 211:278-282.
219. Wang Q., Theriault A., Gapor A., Adeli K. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway. Biochem Biophys Res Commun 1998, 246:640-643.
220. Theriault A., Wang Q., Gapor A., Adeli K. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler Thromb Vasc Biol 1999, 19:704-712.
221. Galli F., Stabile A.M., Betti M., Conte C., Pistilli A., Rende M., et al. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch Biochem Biophys 2004, 423:97-102.
222. Brigelius-Flohe R. Induction of drug metabolizing enzymes by vitamin E. J Plant Physiol 2005, 162:797-802.
223. Clarke M.W., Burnett J.R., Croft K.D. Vitamin E in human health and disease. Crit Rev Clin Lab Sci 2008, 45:417-450.
224. Yap W.N., Zaiden N., Tan Y.L., Ngoh C.P., Zhang X.W., Wong Y.C., et al. Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Lett 2010, 291:187-199.
225. McIntyre B.S., Briski K.P., Tirmenstein M.A., Fariss M.W., Gapor A., Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 2000, 35:171-180.
226. Wali V.B., Sylvester P.W. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 2007, 42:1113-1123.
227. Saito H., Kiyose C., Yoshimura H., Ueda T., Kondo K., Igarashi O. Gamma-tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor. J Lipid Res 2003, 44:1530-1535.
228. Kausar H., Bhasin G., Zargar M.A., Athar M. Palm oil alleviates 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion response in murine skin. Cancer Lett 2003, 192:151-160.
229. Nesaretnam K., Ambra R., Selvaduray K.R., Radhakrishnan A., Reimann K., Razak G., et al. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 2004, 39:459-467.
230. Yamada Y., Obayashi M., Ishikawa T., Kiso Y., Ono Y., Yamashita K. Dietary tocotrienol reduces UVB-induced skin damage and sesamin enhances tocotrienol effects in hairless mice. J Nutr Sci Vitaminol (Tokyo) 2008, 54:117-123.
231. Yap W.N., Zaiden N., Luk S.Y., Lee D.T., Ling M.T., Wong Y.C., et al. In vivo evidence of gamma-tocotrienol as a chemosensitizer in the treatment of hormone-refractory prostate cancer. Pharmacology 2010, 85:248-258.
232. Qureshi A.A., Salser W.A., Parmar R., Emeson E.E. Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice. J Nutr 2001, 131:2606-2618.
233. Newaz M.A., Yousefipour Z., Nawal N., Adeeb N. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol. J Physiol Pharmacol 2003, 54:319-327.
234. Nakano M., Onodera A., Saito E., Tanabe M., Yajima K., Takahashi J., et al. Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats. J Nutr Sci Vitaminol (Tokyo) 2008, 54:329-334.
235. Ima-Nirwana S., Kiftiah A., Sariza T., Gapor Abd., Khalid M.T.B.A.K. Palm vitamin E improves bone metabolism and survival rate in thyrotoxic rats. Gen Pharmacol 1999, 32:621-662.
236. Rukmini C., Raghuram T.C. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J Am Coll Nutr 1991, 10:593-601.
237. Khor H.T., Ng T.T. Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity. Int J Food Sci Nutr 2000, 51(Suppl.):S3-S11.
238. Poveda E., Ayala P., Milena R., Ordonez E., Baracaldo C., Delgado W., et al. Effects of vegetal oil supplementation on the lipid profile of Wistar rats. Biomedica 2005, 25:101-109.
239. Gupta A., Chopra K. Effect of tocotrienols on iron-induced renal dysfunction and oxidative stress in rats. Drug Chem Toxicol 2009, 32:319-325.
240. Fairus S., Nor R.M., Cheng H.M., Sundram K. Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of alpha-tocopherol. Am J Clin Nutr 2006, 84:835-842.
241. Radhakrishnan A.K., Lee A.L., Wong P.F., Kaur J., Aung H., Nesaretnam K. Daily supplementation of tocotrienol-rich fraction or alpha-tocopherol did not induce immunomodulatory changes in healthy human volunteers. Br J Nutr 2009, 101:810-815.
242. Rautalahti M., Albanes D., Hyvonen L., Piironen V., Heinonen M. Effect of sampling site on retinol, carotenoid, tocopherol, and tocotrienol concentration of adipose tissue of human breast with cancer. Ann Nutr Metab 1990, 34:37-41.
243. Nesaretnam K., Gomez P.A., Selvaduray K.R., Razak G.A. Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia. Asia Pac J Clin Nutr 2007, 16:498-504.
244. Weinstein S.J., Wright M.E., Lawson K.A., Snyder K., Mannisto S., Taylor P.R., et al. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1253-1259.
245. Nur Azlina M.F., Nafeeza M.I. Tocotrienol and alpha-tocopherol reduce corticosterone and noradrenalin levels in rats exposed to restraint stress. Pharmazie 2008, 63:890-892.
246. Kamat J.P., Devasagayam T.P. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett 1995, 195:179-182.
247. Raederstorff D., Elste V., Aebischer C., Weber P. Effect of either gamma-tocotrienol or a tocotrienol mixture on the plasma lipid profile in hamsters. Ann Nutr Metab 2002, 46:17-23.
248. Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., Akaike A. Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 2004, 47:904-915.
249. Palozza P., Verdecchia S., Avanzi L., Vertuani S., Serini S., Iannone A., et al. Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells. Mol Cell Biochem 2006, 287:21-32.
250. Song B.L., DeBose-Boyd R.A. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem 2006, 281:25054-25061.